Matthew A. Ciorba

Matthew A. Ciorba, MD

  • Gastroenterology
  • Inflammatory Bowel Disease
Video Profile

Sees Patients For

Gastroenterology, inflammatory bowel disease, Crohn's disease

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital

Board Certifications

  • Internal Medicine

Academic Title(s)

Associate Professor, Medicine
Division of Gastroenterology
Director, Inflammatory Bowel Disease Program

Languages

  • English

Education

Fellowship

2007 Gastroenterology, Washington University School of Medicine, St. Louis, Missouri

Residency

2003 Internal Medicine, Washington University School of Medicine, St. Louis, Missouri

M.D.

2001 University of Iowa College of Medicine, Iowa City, Iowa

B.S.

1996 Exercise Science, University of Iowa College of Liberal Arts, Iowa City, Iowa

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: AbbottRoyalties: $1 - $9,999Equity: NoConsulting/Advisory Board: $1 - $9,999Speaker Fees: $10,000 - $19,999Reporting Date: 05/01/2020
Company Name: Takeda Pharmaceuticals, Inc.Royalties: $1 - $9,999Equity: NoConsulting/Advisory Board: $1 - $9,999Speaker Fees: $20,000 - $39,999Reporting Date: 05/01/2020